首页> American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons> Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: A randomized trial

Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: A randomized trial

导出原文传递

翻译打印收藏纠错

作者： Andreassen,A.K. ^[1] ; Andersson,B. ^[2] ; Gustafsson,F. ^[3] ; Eiskj?r,H. ^[4] ; Gude,E. ^[5] ; Jansson,K. ^[6] ; Solbu,D. ^[7] ; Sigurdardottir,V. ^[8] ; Arora,S. ^[9] ; Dellgren,G. ; Gullestad,L.

作者单位： Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ^[1] Department of Cardiology, Heart and Medicine Center County Council of Ostergotland, Linkoping ^[2] Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden ^[3] Department of Cardiology, Rigshospitalet, Copenhagen, Denmark ^[4] Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, K.G. Jebsen ^[5] Novartis Norge AS, Oslo, Norway ^[6] Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, The Clinic for ^[7] Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway ^[8] Department of Cardiology, Aarhus University Hospital, Skejby, Denmark ^[9]

关键词 Clinical research/practice heart transplantation/cardiology immunosuppressant immunosuppression/immune modulation immunosuppressive regimens mechanistic target of rapamycin: everolimus minimization/withdrawal

发布时间 2014-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交